D.R. Horton, Inc.

DHI

CIK 0000882184 · Quarterly mode · latest period FY2026 (Q1) (ending 2026-03-31) · sourced from SEC EDGAR

At a glance · FY2026 (Q1)

Revenue
$7.56B
↓-2.3% -$176Mvs FY2025 (Q1)
Operating Income
$705M
↓-22.7% -$207Mvs FY2025 (Q1)
Net Income
$648M
↓-20.1% -$163Mvs FY2025 (Q1)
Gross Profit
$1.70B
↓-10.4% -$197Mvs FY2025 (Q1)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Poor
11/100
  • Profitability
    0Insufficient data
  • Liquidity
    0Insufficient data
  • Leverage
    0Insufficient data
  • Efficiency
    58Asset Turnover 0.96x (1.0+ = capital-efficient)
  • Growth
    9Revenue YoY -2.3% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Insufficient data

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project DHI's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

3%

Trailing 3-yr CAGR was -7.6%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$147.91
Total enterprise IV
$45.84B
Diluted shares
0.31B
Terminal PV
$32.30B (70% of total)
Year-5 FCF
$3.81B
YearProjected FCFDiscounted PV
+1$3.38B$3.07B
+2$3.48B$2.88B
+3$3.59B$2.70B
+4$3.70B$2.52B
+5$3.81B$2.36B
Terminal$52.02B$32.30B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$154M
investment in PP&E
Dividends paid (TTM)
$502M
cash returned to holders
Stock buybacks (TTM)
$3.30B
share count reduction
Stock-based comp (TTM)
$132M
non-cash dilution

Balance sheet · 2026-03-31

latest filed snapshot
Total assets
$35.57B
everything owned
Total liabilities
$11.37B
everything owed
Stockholders' equity
$23.63B
shareholder claim

Recent performance · 68 quarters

Revenue↓-2.3% -$176M
$7.56B
Net Income↓-20.1% -$163M
$648M
Free Cash Flow↓-8.5% -$3M
$-37M

Drill down